Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the repurchase of $1 billion (1.9 million shares) of its common stock. As of December 3, 2024, $3 billion remained available under the company’s share repurchase authorization.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Media: Sandy Pound 781-622-1223 sandy.pound@thermofisher.com

Investor: Rafael Tejada 781-622-1356 rafael.tejada@thermofisher.com

Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
Von Dez 2024 bis Jan 2025 Click Here for more Thermo Fisher Scientific Charts.
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
Von Jan 2024 bis Jan 2025 Click Here for more Thermo Fisher Scientific Charts.